Azurity Pharmaceuticals
↗Woburn, USA
Azurity Pharmaceuticals is a privately held specialty pharmaceutical company that focuses on developing and commercializing innovative products for underserved patient populations, particularly children and the elderly. The company specializes in dose-form innovation, transforming traditional tablets and capsules into oral liquids and other patient-friendly formulations to improve adherence and outcomes.
Formed through the merger of CutisPharma and Silvergate Pharmaceuticals, Azurity has grown rapidly through strategic acquisitions of companies like Arbor Pharmaceuticals, Slayback Pharma, and Covis Pharma. The company maintains a robust portfolio across cardiovascular, CNS, endocrinology, gastrointestinal, and oncology markets, with a strong emphasis on 505(b)(2) regulatory pathways and orphan drug designations.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Therapeutics & Drug Delivery
SIZE & FINANCIALS
Employees:501-1000
Revenue:$250M-$500M
Founded:2000
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$919M
Investors:QHP Capital, Ampersand Capital Partners, NovaQuest Private Equity, Schroders Capital
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Oral liquids, Complex injectables, Transdermal patches
Active Trials:111
Trial Phases:Phase 1: 5 | Phase 2: 8 | Phase 3: 12 | Phase 4: 4
FDA Approvals:43
EMA Approvals:2
CORPORATE STRUCTURE
Subsidiaries:Arbor Pharmaceuticals, Slayback Pharma, Covis Pharma, Silvergate Pharmaceuticals
Key Partnerships:ACA Pharma (Exclusive distribution in Asia for Ferabright), George Medicines Ltd (Global collaboration)
COMPETITION
Position:Leader
Competitors:Recordati, AMAG Pharmaceuticals, ProMetic Life Sciences, Ethypharm, Prometheus Laboratories
LEADERSHIP
Key Executives:
Ronald L. Scarboro - CEO
Ajay Singh - Chief Scientific Officer
Raghav Chari - Chief Business & Innovation Officer
Scientific Founders:Neal I. Muni
Board Members:Amit Patel (Chairman), Vern Davenport, Jeff Edwards, Rajiv De Silva
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Azurity Pharmaceuticals. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.